Taiwan Surrogacy: Clinics, Agencies, Contracts and Payments — Legal Risks
The legal decision before paying
Taiwan does not presently provide an established legal route for a clinic to carry out a surrogacy programme under its Assisted Reproduction Act. A licensed fertility centre may offer certain assisted-reproduction services to eligible patients; that licence is not authority to recruit a gestational carrier, transfer an embryo to her or promise an intended-parent birth registration. Do not treat an agency brochure, an invoice or a signed agreement as proof that the proposed surrogacy treatment is lawful. Before paying, identify the actual medical procedure, its location and the legal basis for each participant's role.
The official consolidated Assisted Reproduction Act page still lists 3 January 2018 as its amendment date; the Legislative Yuan record shows continued committee consideration of amendment proposals on 16 July 2026. The Ministry’s December 2025 announcement describes broader access to assisted reproduction, but does not itself establish a surrogacy route. No later promulgated amendment was verified in the sources; confirm the official text and commencement date immediately before any commitment or treatment.
Analyse Taiwan as a separate legal jurisdiction and distinguish five actors: intended parents, the person who would carry the pregnancy, the treating clinic, the recruiter or coordinator, and the person receiving funds. A foreign contract or an offshore company changes neither the Taiwanese regulatory character of work actually performed in Taiwan nor the need to examine the foreign place of treatment separately. Permission for ordinary IVF, consent to treatment, commercial solicitation, civil enforceability and legal parentage are different questions. No single approval answers all five.
Clinic permissions and the role of intermediaries
Article 6 of the Assisted Reproduction Act requires medical institutions to obtain the competent authority's permission before performing regulated assisted reproduction or handling donated gametes; authorised charitable bodies have a narrower role concerning sperm. The authorisation lasts three years under the Act and is governed by the institution-permit regulations. Ask for the precise permitted activity, the institution's legal identity and a currently valid permit, confirmed with the regulator rather than supplied only as a marketing screenshot. A general business registration or hospital reputation is insufficient. Article 5 has a narrow exception for placing a husband's extracted sperm into his wife's body; Article 16(3) and its associated penalty still apply. It is not an exception allowing a third person to carry the pregnancy.
Under Articles 7, 11 and 12, authorised treatment is conditional on prescribed medical and genetic assessments, the qualifying couple's circumstances and informed written consent. Article 11 also contains a route for approval where there is another medically justified reason despite absence of its ordinary infertility or genetic-disease ground; that exception does not create a surrogacy entitlement. The clinic must explain necessity, method, success prospects, complications, risks and alternatives. Additional notarised consent rules apply in specified donor situations. Do not convert any of these consents into a promise of a live birth.
Gamete donation is not the sale of eggs, sperm or embryos. Article 8 requires donation without remuneration and permits specified nutritional or necessary medical, transport and lost-work expenses within the authority's limits. Article 31 separately criminalises selling or brokering gametes or embryos with intent to profit. These provisions concern donors and reproductive material; they do not establish a permitted fee schedule for a surrogate. A supplier's label such as “reimbursement”, “gift”, or “coordination” cannot settle the legal nature of a payment if its substance is different. Article 8 contemplates eligible donor-expense support arranged through the authorised reproductive institution at the receiving couple's request; it does not create an open-ended entitlement to transfer money directly to a donor.
A clinic and an agency must be examined separately. A medical institution's reproductive-treatment permit cannot simply be lent to an unrelated intermediary. Coordination, interpretation and document assistance may be distinguishable from treating patients, recruiting a surrogate, arranging gamete sales or advertising clinical services; however their legality depends on the precise conduct, parties and applicable rules. No blanket statutory licence for a “surrogacy agency” is known, and not every administrative service is unlawful. Require a written service-by-service legal explanation before engaging either provider.
Articles 84 and 87 of Taiwan's Medical Care Act regulate who may place medical advertisements and when promotional material is treated as medical advertising. Non-medical businesses cannot assume that describing their offer as “information”, “consulting” or a foreign programme avoids those rules. A local health authority's October 2026 enforcement announcement illustrates scrutiny of online assisted-reproduction promotion; it does not determine the legality of every coordinator. Check the actual website, social-media posts, referral promises, payment flow and jurisdiction of solicitation, and obtain advice before publishing or purchasing advertised services.
Transaction risk matrix
| Proposed activity or payment | Legal assessment and next check |
|---|---|
| Licensed-clinic IVF | potentially within the regulated medical pathway only for eligible recipients, approved activities, required evaluation and informed consent. The clinic's IVF permit does not authorise a separate gestational carrier. Verify the current permit and the actual treatment plan rather than relying on the word “licensed”. |
| Carrier recruitment or embryo transfer to a carrier in Taiwan | no established authorising surrogacy pathway has been identified in the current Act. Treat recruitment fees, carrier compensation and promised parentage as high-risk and obtain independent Taiwanese legal advice before signing or funding. Do not infer that an unpaid arrangement is automatically permitted. |
| Sale or brokerage of gametes or embryos for profit | Article 31 creates a specific criminal risk for profit-motivated sale or brokerage of reproductive material. Distinguish this from permitted, capped donor-related expense support under Article 8. Demand a detailed description of what the intermediary actually supplies and who gets paid. |
| A package mixing Taiwan consultations and treatment abroad | examine the law of the actual treatment state as well as Taiwanese advertising, consumer, payment and possible medical rules for steps in Taiwan. A foreign clinic's availability is not Taiwanese authorisation, a travel guarantee or recognition of intended parentage. Demand named counterparties and an allocation of each service and fee by country. |
What contracts can and cannot achieve
Before signing, separate the medical-treatment agreement, any administrative or translation agreement, gamete-storage documents, and any proposed carrier arrangement. Identify each legal entity, clinician and jurisdiction, the actual service, milestone, currency and recipient bank account. Demand clear statements on screening, clinical discretion, risks, data privacy, record custody, cancellation, refund triggers, choice of law, courts and complaint channels. The person invoicing may not be the clinician who performs treatment. Each agreement must be reviewed on its own terms and alongside the entire package.
A private agreement cannot confer a medical permission that statute withholds. Nor can signatures alone compel implantation, continuing pregnancy, transfer of a child, a registration result or recognition of intended-parent status. Whether a particular disputed clause is void, severable, refundable or otherwise enforceable requires an individual Taiwanese civil-law analysis, including mandatory rules and public policy; it is unsafe to declare every related contract automatically void. If there is an offshore element, conflict-of-laws and the foreign forum may change remedies but not erase Taiwanese regulation of local acts. Taiwan Civil Code Article 71 generally renders legal acts contrary to mandatory or prohibitory rules void, unless that rule does not require invalidity; Article 72 addresses acts contrary to public order or good morals. For an international contract, Articles 7, 8 and 20 of Taiwan's Act Governing the Choice of Law in Civil Matters Involving Foreign Elements address avoidance of mandatory local rules, public policy and contractual choice of law. Whether they affect any particular clause or refund still depends on the facts.
Use staged, traceable payments only after the legality and identity of the beneficiary are checked. Obtain an itemised price showing medical services, medication, storage, coordination, travel, taxes, lawful donor expenses and any carrier-related sums separately. Ask when money becomes non-refundable; who holds deposits; whether escrow is independently regulated; what happens if authorisation, screening or a visa fails; and whether an overseas transfer is reversible. No official Taiwanese surrogacy tariff or guaranteed-refund rule has been established for this guide. Avoid cash, personal wallets and unexplained third-party transfers.
An intended parent paying documented permissible donor expenses under Article 8 is not the same as paying a carrier for pregnancy. Even donor expenses require the applicable official ceiling and eligible expense categories to be checked. Conversely, a medical consultation or translation fee is not automatically unlawful merely because a fertility-related agency charges it. Classification turns on facts: is the payment for an authorised service, a prohibited or unapproved procedure, gamete brokerage, or an activity performed in another jurisdiction? Record that answer before deciding whether to pay, refuse or seek a refund.
Documents, checks and warning signs
Treat the following as stop signs, not as proof of a specific offence: a claimed secret “Taiwan surrogacy licence”; refusal to name the carrier's independent adviser; a guaranteed birth certificate or passport; an “all-inclusive” price with no beneficiaries; pressure to wire funds before eligibility assessment; instructions to disguise carrier compensation as donor expenses; or a contract that conceals where embryo transfer will occur. Preserve screenshots and written representations. A provider's confident assertion is not evidence of regulatory permission.
Request the clinic's full registered name and current permit; proposed treatment protocol and geographic locations; identity and registration of each intermediary; itemised contracts and invoices; written assessment of the patient's eligibility and required consents; precise gamete origin and handling; privacy and medical-record terms; cancellation/refund schedules; and evidence of the destination account owner. If a carrier is involved, obtain a separate independent legal opinion addressing her status, free consent and safeguards. Do not send sensitive medical or identity records through unverified channels.
A practical order is: (1) obtain the complete documents without paying an irrevocable deposit; (2) verify the clinic's authorised activities with Taiwan's Ministry of Health and Welfare or the relevant competent authority; (3) have independent local counsel classify the Taiwan-based conduct and check any agency advertising; (4) examine actual foreign treatment law separately; (5) match each contract with its payee and milestone; and (6) decide whether to proceed with a lawful medical service, renegotiate or stop. Verbal assurances should be converted into verifiable written answers.
If a payment or arrangement has already been made
If funds have already moved, do not send a second payment merely to “unlock” a refund. Gather dated advertisements, messages, signed versions, invoices, bank instructions, transfer confirmations and proof of the promised service. Notify the provider in writing of the exact disputed item, request its regulatory basis and an itemised accounting, and preserve response deadlines. Ask the bank promptly about a recall or fraud process where applicable; the result depends on payment method and facts. Protect sensitive patient data when supplying evidence.
Possible responses depend on who did what and where: contractual negotiation or civil recovery, a complaint to a competent health authority about regulated medical activity or advertising, and, where specific facts suggest criminal gamete trading or fraud, advice on reporting to investigators. Do not threaten criminal complaints simply to gain leverage. Confirm forum, governing law, limitation periods, evidence admissibility and whether a clause appointing arbitration or a foreign court is effective. This guide does not establish that a particular refund or damages claim will succeed.
Practical scenario and next decision
Example: a Taipei consultant offers a single invoice for “Taiwan IVF + matching + birth documents”, takes a deposit into an individual account and says a partner clinic abroad will perform the transfer. The correct first step is not to decide that the whole package is legal or illegal. Separate the Taiwan advertisement and matching work, the permitted scope of any Taiwan clinic, the actual destination and carrier arrangements, each beneficiary and the proposed parentage documents. Withhold new irreversible funds until independent counsel has assessed those elements; a foreign treatment location does not cure misleading local promises.
Even if a medical procedure is lawful in the place where it occurs, naming the intended parents on a document, recognising their status elsewhere and obtaining travel documents remain distinct issues. Do not rely on a clinic's guarantee that Taiwan or another state will record particular adults as parents or issue nationality documents. For an international case, counsel in the treatment country and each relevant country of nationality or residence must assess the actual parentage and immigration route. Those procedures are outside this Taiwan transaction-risk article.
The decision rule is practical: pay only for a specifically identified service whose provider, legal basis, location and recipient have been checked, and whose cancellation consequences you understand. For a proposed carrier programme involving acts in Taiwan, pause rather than rely on a surrogacy contract or clinic marketing. Ask Taiwan-qualified counsel to recheck the law in force at signature and treatment dates, the governing permits, any intermediary's conduct and civil remedies.
Primary legal and official sources
- Taiwan Assisted Reproduction Act (人工生殖法), consolidated official legislation, amended 2018-01-03
- Taiwan Medical Care Act (醫療法), official consolidated law, amended 2026-09-23
- Regulations for Assisted Reproduction Institution Permit (人工生殖機構許可辦法)
- Ministry of Health and Welfare: Executive Yuan passed Assisted Reproduction Act amendment proposal, December 2025
- Legislative Yuan joint committee meeting, 16 July 2026
- Taipei District Prosecutors Office, public explanation of Assisted Reproduction Act
- Kaohsiung health authority, 23 October 2026, online assisted-reproduction advertising enforcement
- Taiwan Civil Code (民法), Articles 71–72; check amendment-specific commencement
- Act Governing the Choice of Law in Civil Matters Involving Foreign Elements (涉外民事法律適用法), Articles 7, 8, 20
